Anadis

#	Item
1	Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development LEXINGTON, Mass. – June 12, 2012 – Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-06 00:38:27 Autoimmune diseases Biologic Pharmacology Human gastrointestinal tract Mucositis Coeliac disease Antibody Anadis Medicine Health Biology
2	Associate Professor Damian Purcell We use ACH2 funding to develop a reliable vaccination regimen of dairy cows with HIV-1 Env oligomers that produces high titers of anti-HIV neutralising antibodies (NAb) in bovine colost Add to Reading List Source URL: ach2.publishpath.com Language: English - Date: 2013-10-31 00:33:09 Breastfeeding Colostrum Nutrition Medicine Anadis HIV Dairy cattle Env Biology Biotechnology Breast milk